Oncothyreon (Nasdaq: ONTY) announced the pricing of previously announced concurrent but separate underwritten offerings of 10,000,000 shares of its Common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE